176 related articles for article (PubMed ID: 32533977)
21. Diltiazem enhances the analgesic but not the respiratory depressant effects of morphine in rhesus monkeys.
Kishioka S; Ko MC; Woods JH
Eur J Pharmacol; 2000 May; 397(1):85-92. PubMed ID: 10844102
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, structure, in vitro pharmacology, and in vivo activity of trans-3,4-dichloro-N-[[1-(dimethylamino)-4-phenylcyclohexyl]methyl]-benzamide (AP01; 4-phenyl-AH-7921), a novel mixed μ-/κ-opioid.
Krstenansky JL; Bacsa J; Zambon A
J Forensic Sci; 2023 May; 68(3):978-989. PubMed ID: 36812253
[TBL] [Abstract][Full Text] [Related]
23. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
[TBL] [Abstract][Full Text] [Related]
24. Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats.
Gottås A; Øiestad EL; Boix F; Vindenes V; Ripel Å; Thaulow CH; Mørland J
Br J Pharmacol; 2013 Oct; 170(3):546-56. PubMed ID: 23865556
[TBL] [Abstract][Full Text] [Related]
25. Are the N-demethylated metabolites of U-47700 more active than their parent compound? In vitro μ-opioid receptor activation of N-desmethyl-U-47700 and N,N-bisdesmethyl-U-47700.
Nordmeier F; Cannaert A; Stove CP; Schmidt PH; Meyer MR; Schaefer N
Drug Test Anal; 2022 Apr; 14(4):713-717. PubMed ID: 34669261
[TBL] [Abstract][Full Text] [Related]
26. Dextromethorphan differentially affects opioid antinociception in rats.
Chen SL; Huang EY; Chow LH; Tao PL
Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
[TBL] [Abstract][Full Text] [Related]
27. Antinociceptive and behavioral effects of synthetic deltorphin analogs.
Negri L; Noviello L; Noviello V
Eur J Pharmacol; 1996 Jan; 296(1):9-16. PubMed ID: 8720471
[TBL] [Abstract][Full Text] [Related]
28. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
29. Supraspinal administration of opioids with selectivity for mu-, delta- and kappa-opioid receptors produces analgesia in amphibians.
Stevens CW; Rothe KS
Eur J Pharmacol; 1997 Jul; 331(1):15-21. PubMed ID: 9274924
[TBL] [Abstract][Full Text] [Related]
30. Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose.
Krieter P; Gyaw S; Crystal R; Skolnick P
J Pharmacol Exp Ther; 2019 Nov; 371(2):409-415. PubMed ID: 30940694
[TBL] [Abstract][Full Text] [Related]
31. The median effective dose of ketamine and gabapentin in opioid-induced hyperalgesia in rats: an isobolographic analysis of their interaction.
Van Elstraete AC; Sitbon P; Benhamou D; Mazoit JX
Anesth Analg; 2011 Sep; 113(3):634-40. PubMed ID: 21642613
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the spinal actions of the mu-opioid remifentanil with alfentanil and morphine in the rat.
Buerkle H; Yaksh TL
Anesthesiology; 1996 Jan; 84(1):94-102. PubMed ID: 8572360
[TBL] [Abstract][Full Text] [Related]
33. Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice.
Hiramatsu M; Inoue K; Ambo A; Sasaki Y; Kameyama T
Br J Pharmacol; 2001 Apr; 132(8):1948-56. PubMed ID: 11309268
[TBL] [Abstract][Full Text] [Related]
34. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
35. KEA-1010, a ketamine ester analogue, retains analgesic and sedative potency but is devoid of Psychomimetic effects.
Harvey M; Sleigh J; Voss L; Bickerdike M; Dimitrov I; Denny W
BMC Pharmacol Toxicol; 2019 Dec; 20(1):85. PubMed ID: 31856925
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor.
Cox EH; Kerbusch T; Van der Graaf PH; Danhof M
J Pharmacol Exp Ther; 1998 Mar; 284(3):1095-103. PubMed ID: 9495871
[TBL] [Abstract][Full Text] [Related]
37. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
Diop L; Rivière PJ; Pascaud X; Junien JL
Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
[TBL] [Abstract][Full Text] [Related]
38. Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of
Gerak LR; Minervini V; Latham E; Ghodrati S; Lillis KV; Wooden J; Disney A; Husbands SM; France CP
J Pharmacol Exp Ther; 2019 Nov; 371(2):507-516. PubMed ID: 31439807
[TBL] [Abstract][Full Text] [Related]
39. First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass.
Vandeputte MM; Verougstraete N; Walther D; Glatfelter GC; Malfliet J; Baumann MH; Verstraete AG; Stove CP
Arch Toxicol; 2022 Jun; 96(6):1865-1880. PubMed ID: 35449307
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data.
Kalvass JC; Olson ER; Cassidy MP; Selley DE; Pollack GM
J Pharmacol Exp Ther; 2007 Oct; 323(1):346-55. PubMed ID: 17646430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
